Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting

9d ago

REPL

PremiumThe Fly

Replimune Group announces inducement grants under Nasdaq listing rule

12d ago

REPL

PremiumPress Releases

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12d ago

REPL

PremiumCompany Announcements

Replimune Group Announces Major Executive Team Overhaul

21d ago

REPL

PremiumPress Releases

Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions

21d ago

REPL

PremiumThe Fly

Replimune Group announces appointment of Patel to CEO, leadership transitions

21d ago

REPL

PremiumThe Fly

Replimune Group price target raised to $12 from $10 at H.C. Wainwright

2M ago

REPL

More REPL News >

REPL News on the Web

2024-03-27

Analysts Are Bullish on Top Healthcare Stocks: Replimune Group (REPL), Merck & Company (MRK)

TipRanks News

Bullish

2024-03-26

Replimune appoints new CEO ahead of drug application

Investing.com

Neutral

2024-03-26

Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions

Yahoo Finance

Bullish

2024-03-11

How Much Upside is Left in Replimune Group, Inc. ? Wall Street Analysts Think 50.17%

Yahoo Finance

Bullish

2024-03-11

How Much Upside is Left in Replimune Group, Inc. (REPL)? Wall Street Analysts Think 50.17%

Zacks

Bullish

2024-03-08

What Makes Replimune Group, Inc. a New Buy Stock

Yahoo Finance

Bullish

2024-03-08

What Makes Replimune Group, Inc. (REPL) a New Buy Stock

Zacks

Bullish

2024-03-06

Replimune to Present at the American Association for Cancer Research Annual Meeting 2024

Yahoo Finance

Neutral

News Score - Last 7 Days

Positive

REPL

Sector Average

Media Buzz

This Week3 articles

Weekly Average2.25 articles

News Sentiment

This Week100%

Sector Average64%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REPL’s Media Buzz Sentiment?

3 articles about REPL were published this week. In an average week, 2.25 articles are published.

What is REPL’s weekly average amount of articles?

In an average week, 2.25 articles about REPL are published.

What is REPL’s News Sentiment?

100% of articles about REPL were positive this week, compared to its sector average of 64%.

Healthcare Stocks that are Trending in the News

STROSutro Biopharma

ERASErasca

THRDThird Harmonic Bio, Inc.

MASIMasimo

STOKStoke Therapeutics

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing